2-((3-(sec-Butylcarbamoyl)phenyl)carbamoyl)cyclohexanecarboxylic acid

Catalog No.: 
ACPCGE702
CAS No.: 
1014018-19-9
Molecular Formula: 
C19H26N2O4
Molecular Weight: 
346.43
2-((3-(sec-Butylcarbamoyl)phenyl)carbamoyl)cyclohexanecarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$221.00InquiryInquiry
5g97%$661.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((3-(sec-Butylcarbamoyl)phenyl)carbamoyl)cyclohexanecarboxylic acid
IUPAC Name2-((3-(sec-butylcarbamoyl)phenyl)carbamoyl)cyclohexane-1-carboxylic acid
Molecular FormulaC19H26N2O4
Molecular Weight346.43
SMILESO=C(C1C(C(NC2=CC=CC(C(NC(C)CC)=O)=C2)=O)CCCC1)O
InChI KeyKJLJHAIVPDONBX-UHFFFAOYSA-N
Synonym2-({3-[(SEC-BUTYLAMINO)CARBONYL]ANILINO}CARBONYL)-CYCLOHEXANECARBOXYLIC ACID;2-[[3-(butan-2-ylcarbamoyl)phenyl]carbamoyl]cyclohexane-1-carboxylic acid;Cyclohexanecarboxylic acid, 2-[[[3-[[(1-methylpropyl)amino]carbonyl]phenyl]amino]carbonyl]-
CAS No.1014018-19-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPCGE702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCGE702 route product structure diagram
    ACPCGE7021014018-19-9
Inquiry

2. ACPCGE702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCGE702 route product structure diagram
    ACPCGE7021014018-19-9
Inquiry

3. ACPCGE702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPCGE702 route product structure diagram
    ACPCGE7021014018-19-9
Inquiry

Comments (0)